Increased tidal volume variability in children is a better marker of opioid-induced respiratory depression than decreased respiratory rate

Journal of Clinical Monitoring and Computing

Volumn 18, Issue 3, 2004, Pages 171-178

  Barbour, Sean J ^a   Vandebeek, Christine A ^b   Ansermino, J Mark ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Opioid; Remifentanil; Respiratory depression; Respiratory rate; Tidal volume; Tidal volume variability

Indexed keywords

PHYSIOLOGY; PULMONARY DISEASES;

OPIOID; RESPIRATORY DEPRESSION; RESPIRATORY RATE; TIDAL VOLUME;

BIOMEDICAL ENGINEERING;

OPIATE; REMIFENTANIL; INTRAVENOUS ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

APNEA; ARTICLE; BREATHING RATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FLOW RATE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; TIDAL VOLUME; BODY SIZE; BREATHING; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; PRESCHOOL CHILD; RESPIRATORY FAILURE;

ANALGESICS, OPIOID; ANESTHETICS, INTRAVENOUS; BODY SIZE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PIPERIDINES; RESPIRATION; RESPIRATORY INSUFFICIENCY; TIDAL VOLUME;

EID: 16644393517     PISSN: 13871307     EISSN: 15732614     Source Type: Journal    
DOI: 10.1023/B:JOCM.0000042922.63647.b9     Document Type: Article

References (12)

1. Bellville W, Seed JC. The effect of drugs on the respiratory response to carbon dioxide. Anesthesiology 1960; 21: 727-741.
2. Monitto CL, Greenberg RS, Kost-Byerly S, et al. The safety and efficacy of parent-/nurse-controlled analgesia in patients less than six years of age. Anesth Analg 2000; 91: 573-579.
3. Institute of Medicine. To Err is Human: Building a Safer Health System. National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) 1999.
4. Doyle E, Harper I, Morton NS. Patient-controlled analgesia with low dose background infusions after lower abdominal surgery in children. Br J Anaesth 1993; 71(6): 818-822.
5. Hoke JF, Shulgman D, Dershwitz M, et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology 1997; 87: 533-541.
6. Dershwitz M, Hoke JF, Roscow CE, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996; 84: 812-820.
7. Ross AK, Davis PJ, Dear GL, et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg 2001; 93(6): 1393-1401.
8. Bouillon T, Bruhn J, Roepcke H, Hoeft A. Opioid-induced respiratory depression is associated with increased tidal volume variability. Eur J Anaesthesiol 2003; 20: 127-133.
9. Pyetan E, Akselrod S. Do the high-frequency indexes of HRV provide a faithful assessment of cardiac vagal tone? A critical theoretical evaluation. IEEE Trans Biomed Eng 2003; 50(6): 777-783.
10. Task Force of the European Society and the North American Society of Pacing and Electrophysiology. Heart rate variability. Circulation 1996; 93: 1043-1065.
11. Babenco DH, Conrad PF, Gross JB. The pharmacodynamic effect of a remifentanil bolus on ventilatory control. Anesthesiology 2000; 92(2): 393-398.
12. Levitsky MG. Pulmonary physiology, 5th ed. New York: McGraw-Hill, 1999: 20-21.